Skip to main content
PMC home page
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 1992 Sep;34(5):313–320. doi: 10.1007/BF01741552

Persistent measles virus infection enhances major histocompatibility complex class I expression and immunogenicity of murine neuroblastoma cells

Jacob Gopas 1, Dganit Itzhaky 1, Yael Segev 1, Samuel Salzberg 2, Barry Trink 2, Noah Isakov 1, Bracha Rager-Zisman 1,✉
PMCID: PMC11038602  PMID: 1347254

Abstract

The effect of persistent measles virus infection on the expression of major histocompatibility complex (MHC) class I antigens was studied. Mouse neuroblastoma cells C1300, clone NS20Y, were persistently infected with the Edmonston strain of measles virus. The persistently infected cell line, NS20Y/MS, expressed augmented levels of both H-2Kk and H-2Dd MHC class I glycoproteins. Activation of two interferon(IFN)-induced enzymes, known to be part of the IFN system: (2′–5′)oligoadenylate synthetase and double-stranded-RNA-activated protein kinase, was detected. Measles-virus-infected cells elicited cytotoxic T lymphocytes that recognized and lysed virus-infected and uninfected neuroblastoma cells in an H-2-restricted fashion. Furthermore, immunization of mice with persistently infected cells conferred resistance to tumor growth after challenge with the highly malignant NS20Y cells. The rationale for using measles virus for immunotherapy is that most patients develop lifelong immunity after recovery or vaccination from this infection. Patients developing cancer are likely to have memory cells. A secondary response induced by measles-virus-infected cells may therefore induce an efficient immune response against non-infected tumour cells.

Key words: MHC class I, Measles virus, Tumor immunogenicity

References

  • 1.Brodeur GM, Fong C. Molecular biology and genetics of human neuroblastoma. Cancer Genet Cytogenet. 1989;41:153. doi: 10.1016/0165-4608(89)90243-4. [DOI] [PubMed] [Google Scholar]
  • 2.Gopas J, Rager-Zisman B, Hammerling GJ, Bar-Eli M, Segal S. The relationship between MHC gene expression and metastasis. Adv Cancer Res. 1989;53:89. doi: 10.1016/s0065-230x(08)60280-8. [DOI] [PubMed] [Google Scholar]
  • 3.Heath WR, Hurd ME, Carbone FR, Sherman LA. Peptide-dependent recognition of H-2Kb by alloreactive cytotoxic T lymphocytes. Nature. 1989;341:749. doi: 10.1038/341749a0. [DOI] [PubMed] [Google Scholar]
  • 4.Hect TT, Summers DF. Effect of vesicular stomatitis virus infection on histocompatibility antigens of L cells. J Virol. 1982;10:578. doi: 10.1128/jvi.10.4.578-585.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Hoon DSB, Banez M, Okun E, Morton DL, Irie RF. Modulation of human melanoma cells by interleukin-4 in combination with gamma interferon or alpha tumor necrosis factor. Cancer Res. 1991;51:2002. [PubMed] [Google Scholar]
  • 6.Hovanessian AG. The double stranded RNA-activated protein kinase induced by interferons: dsRNA-PK. J Interferon Res. 1989;9:641. doi: 10.1089/jir.1989.9.641. [DOI] [PubMed] [Google Scholar]
  • 7.Hunter WM, Greenwood FC. Preparation of iodine human growth hormone of high specific activity. Nature. 1962;194:495. doi: 10.1038/194495a0. [DOI] [PubMed] [Google Scholar]
  • 8.Ito T, Wang D-Q, Marus M, Nakagima K, Kato S, Kurimura T, Wakamiya R. Antitumor efficacy of vaccinia virus modified tumor cell vaccine. Cancer Res. 1990;50:6915. [PubMed] [Google Scholar]
  • 9.Jacobson S, Sekaly RP, Jacobson CL, McFarland HR, Long EO. HLA class II restricted presentation of cytoplasmic measles virus antigens to cytotoxic cells. J Virol. 1989;63:1756. doi: 10.1128/jvi.63.4.1756-1762.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Jennings SR, Rice PL, Kloszewski ED, Anderson RW, Thompson DL, Tevethia SS. Effect of herpes simplex types 1 and 2 on surface expression of class I major histocompatibility complex antigens on infected cells. J Virol. 1985;55:77. doi: 10.1128/jvi.56.3.757-766.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Ju G, Udem SA, Rager-Zisman B, Bloom BR. Isolation of a heterogenous population of temperature sensitive mutants of measles virus from persistently infected human lymphoblastoid cell lines. J Exp Med. 1978;147:1637. doi: 10.1084/jem.147.6.1637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Kast WM, Offringa R, Peter PJ, Voordouw AC, Meloen RH, van der Eb, Melief CJM. Eradication of adenovirus E1-induced tumors by EIA specific cytotoxic T lymphocytes. Cell. 1989;59:603. doi: 10.1016/0092-8674(89)90006-8. [DOI] [PubMed] [Google Scholar]
  • 13.Kerber B, Mermod N, Hood L, Stroynowski I. Regulation of gene expression by interferons: control of H-2 promoter responses. Science. 1988;239:130214. doi: 10.1126/science.3125612. [DOI] [PubMed] [Google Scholar]
  • 14.Kiessling R, Klein E, Wigzell H. Natural killer cells in the mouse: 1. Cytotoxic cells with specificity for mouse Moloney leukemic cells. Eur J Immunol. 1975;5:112. doi: 10.1002/eji.1830050208. [DOI] [PubMed] [Google Scholar]
  • 15.Kronenberg M, Siu G, Hood LE, Shastri N. The molecular genetics of the T-cell antigen receptor and T-cell antigen recognition. Annu Rev Immunol. 1986;4:529. doi: 10.1146/annurev.iy.04.040186.002525. [DOI] [PubMed] [Google Scholar]
  • 16.Lampson L, Fisher CA. Weak HLA and beta-2-microglobulin expression on neuronal cell lines can be modulated by interferon. Proc Natl Acad Sci USA. 1984;81:6476. doi: 10.1073/pnas.81.20.6476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Long EO. Intracellular traffic and antigen processing. Immunol Today. 1989;10:232. doi: 10.1016/0167-5699(89)90259-4. [DOI] [PubMed] [Google Scholar]
  • 18.Margulis DH. Naked or peptide clothed MHC? Nature. 1989;342:124. doi: 10.1038/342124a0. [DOI] [PubMed] [Google Scholar]
  • 19.Offerman MK, Faller DV. Autocrine induction of major histocompatibility complex class I antigen expression results from induction of beta interferon in oncogene-transformed Balb/c-3T3 cells. Mol Cell Biol. 1989;9:1989. doi: 10.1128/mcb.9.5.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Oldstone MBA, Blount P, Southern PJ, Lampert PW. Cytoimmunotherapy for persistent virus infection reveals a unique clearance pattern from the central nervous system. Nature. 1986;321:239. doi: 10.1038/321239a0. [DOI] [PubMed] [Google Scholar]
  • 21.Rager-Zisman B, Ju G, Rajan TV, Bloom BR. Decreased expression of H-2 antigens following acute measles virus infection. Cell Immunol. 1981;59:319. doi: 10.1016/0008-8749(81)90412-3. [DOI] [PubMed] [Google Scholar]
  • 22.Rager-Zisman B, Egan J, Kress Y, Bloom BR. Isolation of cold sensitive mutants of measles virus from persistently infected murine neuroblastoma cells. J Virol. 1984;51:845. doi: 10.1128/jvi.51.3.845-855.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Rotzschke O, Falk K, Deres K, Schild H, Norda M, Metzger J, Jung G, Rammensee HG. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells. Nature. 1990;348:252. doi: 10.1038/348252a0. [DOI] [PubMed] [Google Scholar]
  • 24.Schirrmacher V, Hoegen VP, Schlag P, Liebrich W, Lehner B, Schumacher K, Ahlrert T, Bastert G. Active specific immunotherapy with autologous tumor cell vaccines modified by Newcastle disease virus: experimental and clinical studies. In: Schirrmacher V, Schwartz-Albeiz R, editors. Cancer metastasis. Berlin Heidelberg: Springer; 1989. p. 157. [Google Scholar]
  • 25.Sheil JM, Bevan MJ, Lefrancois L. Characterization of dual reactive H-2Kb restricted antivesicular stomatitis virus and alloreactive cytotoxic T cells. J Immunol. 1987;138:3654. [PubMed] [Google Scholar]
  • 26.Shimizu Y, Hasumi K, Kazumasa M, Okudaira Y. Immunotherapy of tumor-bearing mice utilizing virus help. Cancer Immunol Immunother. 1988;27:223. doi: 10.1007/BF00205443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Staeheli P. Interferon-induced proteins and the antiviral state. Adv Virus Res. 1990;38:147. doi: 10.1016/s0065-3527(08)60862-3. [DOI] [PubMed] [Google Scholar]
  • 28.Sugimoto T, Horii Y, Hino T, Kemshead JT, Kuroda H, Sawada T, Morioka H, Imanishi J, Inoko H. Differential susceptibility of HLA class II antigens induced by gamma-interferon in human neuroblastoma cell lines. Cancer Res. 1988;49:1824. [PubMed] [Google Scholar]
  • 29.Sweester MT, Morrison LA, Braciale LL, Braciale TJ. Recognition of pre-processed endogenous antigen by class I but not class II restricted cells. Nature. 1989;342:180. doi: 10.1038/342180a0. [DOI] [PubMed] [Google Scholar]
  • 30.Tanaka K, Isselbacher KJ, Khoury G, Jay G. Reversal of oncogenesis by the expression of a major histocompatibility complex class I gene. Science. 1984;228:26. doi: 10.1126/science.3975631. [DOI] [PubMed] [Google Scholar]
  • 31.Tanaka K, Yoshioka T, Bieberich C, Jay G. Role of major histocompatibility complex class I in tumor growth and metastasis. Annu Rev Immunol. 1988;6:359. doi: 10.1146/annurev.iy.06.040188.002043. [DOI] [PubMed] [Google Scholar]
  • 32.Taylor PM, Davey J, Howland K, Rothbard JB, Askonas BA. Class I MHC molecules rather than other mouse genes dictate influenza epitope recognition by cytotoxic T cells. Immunogenetics. 1987;36:267. doi: 10.1007/BF00346521. [DOI] [PubMed] [Google Scholar]
  • 33.Watanabe Y, Kuribayashi K, Miyatake S, Nishihara K, Nakayama E, Taniyama T, Sakala T. Exogenous expression of mouse interferon gamma cDNA in mouse neuroblastoma C1300 results in reduced tumorigenicity by augmented anti-tumor immunity. Proc Natl Acad Sci USA. 1989;86:9456. doi: 10.1073/pnas.86.23.9456. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Wolfson M, Karotza A, Segal S, Rager-Zisman B. Effect of persistent measles virus infection on protein kinase C activity and c-fos protooncogene expression in neuroblastoma cells. FEBS Lett. 1990;250:367. doi: 10.1016/0014-5793(89)80757-4. [DOI] [PubMed] [Google Scholar]
  • 35.Wong GHW, Bartlett PF, Clark-Lewis I, McKiman-Breschkin JL, Schrader JW. Interferon-gamma induces the expression of H-2 and Ia antigens on brain cells. J Neuroimmunol. 1985;7:255. doi: 10.1016/s0165-5728(84)80026-0. [DOI] [PubMed] [Google Scholar]
  • 36.Vaessen RT, Houwelling MJ, Israel A, Kourlisky P, van der Eb AJ. Adenovirus EIA-mediated regulation of class I MHC expression. EMBO J. 1986;5:335. doi: 10.1002/j.1460-2075.1986.tb04217.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Van Bleek GM, Nathenson SG. Isolation of an endogenously processed immunodominant viral peptide from the class I H-2Kb molecule. Nature. 1990;348:213. doi: 10.1038/348213a0. [DOI] [PubMed] [Google Scholar]
  • 38.Vasmel WL, Sijts EJAL, Leupers CJM, Matthews EA, Melief CJM. Primary virus induced lymphomas evade T cell immunity by failure to express viral antigens. J Exp Med. 1989;169:1233. doi: 10.1084/jem.169.4.1233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Weber JS, Rosenberg SA. Modification of murine tumor major histocompatibility antigens by cytokines in vivo and in vitro. Cancer Res. 1988;48:5818. [PubMed] [Google Scholar]
  • 40.Yewdell JW, Bennink JR, Eager KB, Ricciardi RP. CTL recognition of adenovirus-transformed cells infected with influenza virus: lysis of anti-influenza CTL parallels adenovirus 2-induced suppression of class I MHC molecules. Virology. 1988;162:236. doi: 10.1016/0042-6822(88)90413-8. [DOI] [PubMed] [Google Scholar]

Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES